PUXANO

Foundation date

04/09/2020

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

PUXANO is a nanotech-fueled biotech company offering a proprietary nanotechnology platform for high-throughput structure-based protein research. Our core business focuses on: (i) epitope mapping, (ii) drug design, (iii) protein engineering and (iv) biosensor development. Our main clients are Pharma and Biotech companies seeking solutions for bottlenecks that cannot be addressed by standard technologies or CRO services. For more information, please visit our website ???.??????.???.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    13 hours ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022

Jobs by PUXANO